National Assembly conducts Injection problems in the extraordinary session on June 30

Published: 2001-06-13 06:58:00

Updated: 2001-06-13 06:58:00

It is expected that revision bill of Pharmaceutical Affairs Law for exclusion of injection from medical plan will be treated in plenary session of National Assembly at the end of June.

Especially, rival parties dissent revision bill of Pharmaceutical Affairs Law from whether general injection ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK